This disclosure relates to peptide products, uses of the same for the preparation of medicaments for use in the treatment of a condition associated with insulin resistance, diabetes, metabolic syndrome, obesity or cardiovascular disease, the peptides comprising the amino acid sequences of SEQ ID NOS. 1117-1122 and/or 1102-1107. The peptides of the disclosure are modified to have a glycoside surfactant group attached.
